BUDA JUICE, INC. (BUDA) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-01-22

Key Insights

Buda Juice, Inc. announced the full exercise of the underwriters' over-allotment option, resulting in $2,999,992.50 in additional gross proceeds from the sale of 399,999 shares in the company's initial public offering.
The exercise of the over-allotment option indicates strong investor demand for Buda Juice's shares and suggests the IPO was well-received in the market.
The additional capital raised from the over-allotment option will provide Buda Juice with more resources to fund its growth and expansion plans as a newly public company.

Want the newest filings?

This analysis covers the filing from 2026-01-22. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-09

Buda Juice, Inc. successfully completed a $20 million initial public offering, issuing 2,666,667 shares of common stock at $7.50 per share on the NYSE American exchange.
The company granted underwriters warrants to purchase an additional 266,667 shares, or 10% of the IPO shares, at an exercise price of $9.375 per share.
Buda Juice adopted a new 2025 Equity Incentive Plan to grant equity-based and cash-based awards to attract, motivate, and retain key employees, directors, and consultants.

Other reports for BUDA JUICE, INC.

Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.